Axon Enterprise, Inc. logo AXON - Axon Enterprise, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $652.14 DETAILS
HIGH: $750.00
LOW: $440.00
MEDIAN: $688.00
CONSENSUS: $652.14
UPSIDE: 56.27%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 85% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong
Trading 45.1% above fair value
Current Price $417.31
Bear Case $161.19 61.4% downside ($161.19 - $417.31) / $417.31 = -61.4% 12% stage 1 growth, 12% discount
Fair Value $287.53 31.1% downside ($287.53 - $417.31) / $417.31 = -31.1% 19% stage 1 growth, 12% discount
Bull Case $443.33 6.2% upside ($443.33 - $417.31) / $417.31 = 6.2% 25% stage 1 growth, 12% discount

Adjust Assumptions

19.5%
12.0%
3.0%

Key Value Driver

FCF growth rate (19% base case)

Terminal Value % of EV 42%
Implied Market Multiple 54.7x
Market is pricing in (growth) 24.5% vs our 19.5% base

Plain-Language Summary

Using a two-stage FCF DCF with 19% growth decelerating over 15 years, discounted at 12%, the base-case intrinsic value is $287.53 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (22 analysts) $652.14
Analyst Range $440.00 – $750.00
Divergence from AlphaVal 56%

Warnings

⚠ Stock-based employee pay equals 508% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.
ℹ Wall Street's average price target is $652.14 (from 22 analysts). Our estimate is 56% below the consensus -- consider that gap carefully.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions